Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues

Princeton (New Jersey) based Sun Pharmaceutical Inc is recalling the affected lot due to "Failed Impurity (Deacetyl Diltiazem Hydrochloride) specification during stability testing and failed dissolution testing at FDA laboratory." The Mumbai-based drug major had produced the lot at its Halol-based manufacturing facility in Gujarat. The affected lot was later distributed in the market by its US-based unit.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/J7IsDfn
via IFTTT